Stem Cell Potency group, lead by Dr. Ángel Raya at the P-CMR[C] and IDIBELL, together with three other research teams from IDIBELL, have been awarded by La Marató 3Cat Foundation.
We are pleased to announce the First RegenBell symposium on Stem Cells and Regenerative Medicine, which will take place on November 27-28th at the Institut d’Estudis Catalans, downtown in Barcelona. The primary goal of the symposium is to establish an inclusive and collaborative platform for scientists interested in Regenerative Medicine.
Stem Cell Potency group, lead by Dr. Ángel Raya at the P-CMR[C] and IDIBELL, together with three other research teams from IDIBELL, have been awarded by La Marató 3Cat Foundation.
We are pleased to announce the First RegenBell symposium on Stem Cells and Regenerative Medicine, which will take place on November 27-28th at the Institut d’Estudis Catalans, downtown in Barcelona. The primary goal of the symposium is to establish an inclusive and collaborative platform for scientists interested in Regenerative Medicine.
Deciphering the functioning of some transcription factors in the formation of the intestine has been the objective of the team led by Professor Kim Bak Jensen, from the Novo Nordisk Foundation of Stem Cell Medicine (reNEW), in which Dr. Jordi Guiu has also participated.
Thanks to the model, the IDIBELL team detected that one of the siblings had an additional genetic variant responsible for the greater severity of the pathology. These models offer the possibility of exploring each patient’s pathology and designing an individualized approach.
The results show that patients with this disorder have abnormal genetic and epigenetic patterns, which could contribute to the development of diverse clinical manifestations, such as compromise the ability of blood cell production.
Dra. M Carolina Florian, group leader at IDIBELL, has been appointed as an ICREA Research Professor. ICREA, the Catalan Institution for Research and Advanced Studies, offers permanent, tenured positions to the most talented and extraordinary scientists and academics to come and work in Catalonia. Over the years these positions have become a synonym for global academic excellence.
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
The work focuses on endogenous blood stem cell rejuvenation as a possible strategy to regenerate tissues and improve the health and life expectancy of the elderly.
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
Researchers from the Karolinska Institute in Sweden, in collaboration with Meritxell Rovira from IDIBELL, the P-CMRC, and the UB show that a recently identified molecule stimulates the formation of new insulin-producing cells in zebrafish and in mammalian tissues.
The mural is located in the CEIP Pinedo of Valencia and is a piece by the artist Marta Lapeña. This is the mural number 27 of the project with which the UPV and Las Naves are filling the Valencian educational centers with science and art, in feminine.
It begins the selection of candidates to carry out a doctoral program in Regenerative Medicine between the SZBL and the IDIBELL. The program will run mainly at SZBL and will have a minimum six months stay at IDIBELL.
SZBL and IDIBELL launch their joint PhD Exchange Program call for 2022, with the aim of fostering collaboration in research between both institutions in the field of Regenerative Medicine and providing exceptional training in the field for graduated students by promoting mobility and allowing interaction with outstanding researchers.
Neurofibromas are tumors of the peripheral nervous system, which develop in people with a hereditary disease, and they are the main cause of death among those people.
One of the hallmarks of Parkinson’s disease is the abnormal accumulation of the α-synuclein protein that causes neuronal death responsible for motor impairments. Dendrimers are highly branched polymers that decrease α-synuclein accumulation in dopaminergic neurons derived from patient stem cells.
Dr. Anna Veiga is leading the project CRISPR/Cas9 human embryo genome editing (GE) for the study of genes related to early embryo development.
To equilibrate the gene expression between XX females and XY males, one of female X chromosomes is inactivated. Researchers from IDIBELL Regenerative Program has discovered that this inactivation is affected in bone marrow aged stem cells.
The research group led by Dr. Alessandra Giorgetti, leader of the research group “Biology of Hematopoietic Stem Cells and Leukemogenesis” of IDIBELL, and professor at the UB, has received a grant of € 15,000 from the GESMD (Spanish Group of Myelodysplastic Syndromes), a group of which Giorgetti is an active member.
With this project, Dr. M Carolina Florian, aims to improve the survival and quality of life of elderly patients undergoing chemotherapy. The project will study the regeneration of bone marrow tissues after cancer therapy and will seek new strategies to enhance it.
We are organizing a scientific session with all the awarded projects, where all participant groups will present the research performed and the collaborations born thanks to these projects.
Stem Cell Potency group, lead by Dr. Ángel Raya at the P-CMR[C] and IDIBELL, together with three other research teams from IDIBELL, have been awarded by La Marató 3Cat Foundation.
We are pleased to announce the First RegenBell symposium on Stem Cells and Regenerative Medicine, which will take place on November 27-28th at the Institut d’Estudis Catalans, downtown in Barcelona. The primary goal of the symposium is to establish an inclusive and collaborative platform for scientists interested in Regenerative Medicine.
Deciphering the functioning of some transcription factors in the formation of the intestine has been the objective of the team led by Professor Kim Bak Jensen, from the Novo Nordisk Foundation of Stem Cell Medicine (reNEW), in which Dr. Jordi Guiu has also participated.
Thanks to the model, the IDIBELL team detected that one of the siblings had an additional genetic variant responsible for the greater severity of the pathology. These models offer the possibility of exploring each patient’s pathology and designing an individualized approach.
The results show that patients with this disorder have abnormal genetic and epigenetic patterns, which could contribute to the development of diverse clinical manifestations, such as compromise the ability of blood cell production.
Dra. M Carolina Florian, group leader at IDIBELL, has been appointed as an ICREA Research Professor. ICREA, the Catalan Institution for Research and Advanced Studies, offers permanent, tenured positions to the most talented and extraordinary scientists and academics to come and work in Catalonia. Over the years these positions have become a synonym for global academic excellence.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
